Non-Selective PDE4 Inhibition Induces a Rapid and Transient Decrease of Serum Potassium in Mice

Non-Selective PDE4 Inhibition Induces a Rapid and Transient Decrease of Serum Potassium in Mice

The analysis of blood samples from mice treated with the PDE4 inhibitor Roflumilast revealed an unexpected reduction in serum potassium levels, while sodium and chloride levels were unaffected. Treatment with several structurally distinct PAN-PDE4 inhibitors, including Roflumilast, Rolipram, RS25344...

Full description

Bibliographic Details
Main Authors:	Abigail Boyd, Peter Lochmaier, Daniel Irelan, Edward Fiedler, Ji Young Lee, Brian Fouty, Lina Abou Saleh, Wito Richter
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Biology
Subjects:	cAMP-phosphodiesterase PDE4 serum potassium adrenergic signaling hypokalemia
Online Access:	https://www.mdpi.com/2079-7737/11/11/1582

Similar Items

Acute PDE4 Inhibition Induces a Transient Increase in Blood Glucose in Mice
by: Daniel Irelan, et al.
Published: (2023-02-01)

Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice
by: Abigail Boyd, et al.
Published: (2021-12-01)

PDE4B Is a Homeostatic Regulator of Cyclic AMP in Dendritic Cells
by: Amy M. Chinn, et al.
Published: (2022-03-01)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
by: Marianna Szczypka
Published: (2020-08-01)

Differential expression and function of PDE8 and PDE4 in effector T cells: Implications for PDE8 as a drug target in inflammation.
by: Amanda G. Vang, et al.
Published: (2016-08-01)

BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis
by: Franziska Elena Herrmann, et al.
Published: (2022-04-01)

Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis
by: Franziska Elena Herrmann, et al.
Published: (2023-05-01)

Functions of PDE3 Isoforms in Cardiac Muscle
by: Matthew Movsesian, et al.
Published: (2018-02-01)

The Role of PDE8 in T Cell Recruitment and Function in Inflammation
by: Paul M. Epstein, et al.
Published: (2021-04-01)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
by: Claire Lugnier
Published: (2022-09-01)

Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential
by: William J. Moss, et al.
Published: (2024-02-01)

cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features
by: Yazdan Hasani Nourian, et al.
Published: (2023-07-01)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
by: Nikoleta Pavlaki, et al.
Published: (2018-01-01)

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation
by: Marie Bielenberg, et al.
Published: (2024-03-01)

CRISPR/Cas9 Knock-Out in Primary Neonatal and Adult Cardiomyocytes Reveals Distinct cAMP Dynamics Regulation by Various PDE2A and PDE3A Isoforms
by: Egor B. Skryabin, et al.
Published: (2023-06-01)

Pyruvate Upregulates Hepatic FGF21 Expression by Activating PDE and Inhibiting cAMP–Epac–CREB Signaling Pathway
by: Yan-Yan Zhao, et al.
Published: (2022-05-01)

Age-Dependent Maturation of iPSC-CMs Leads to the Enhanced Compartmentation of β<sub>2</sub>AR-cAMP Signalling
by: Alveera Hasan, et al.
Published: (2020-10-01)

PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling
by: Stefania Monterisi, et al.
Published: (2017-05-01)

PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis
by: Federica Barbagallo, et al.
Published: (2020-04-01)

The Sleep Quality- and Myopia-Linked PDE11A-Y727C Variant Impacts Neural Physiology by Reducing Catalytic Activity and Altering Subcellular Compartmentalization of the Enzyme
by: Irina Sbornova, et al.
Published: (2023-12-01)

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
by: Xudan Yang, et al.
Published: (2023-02-01)

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
by: Maria Lukács Krogager, et al.
Published: (2020-08-01)

Serum Potassium Levels and Mortality in Hospitalized Heart Failure Patients
by: Bo-Ping Huang, et al.
Published: (2023-08-01)

Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D
by: Zhe Qiang, et al.
Published: (2018-11-01)

Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury
by: Femke Mussen, et al.
Published: (2023-05-01)

The Dlt and LiaFSR systems derepress SpeB production independently in the Δpde2 mutant of Streptococcus pyogenes
by: Sabrina Faozia, et al.
Published: (2023-11-01)

Clinical Implication of Phosphodiesterase-4-Inhibition
by: Martin Alexander Schick, et al.
Published: (2022-01-01)

A Promising Biomolecule Able to Degrade Neutrophil Extracellular Traps: <i>Cdc</i>PDE, a Rattlesnake Phosphodiesterase
by: Isadora Oliveira, et al.
Published: (2023-01-01)

Long-Acting β2 Adrenergic Receptor Agonist Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesion by Regulating Keratinocyte Proliferation and Apoptosis
by: Rui Xu, et al.
Published: (2022-06-01)

Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus
by: Susan McQuown, et al.
Published: (2019-02-01)

Functional Significance of the Adcy10-Dependent Intracellular cAMP Compartments
by: Sofya Pozdniakova, et al.
Published: (2018-05-01)

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
by: Roberta Kurelic, et al.
Published: (2021-10-01)

In Search of Monocot Phosphodiesterases: Identification of a Calmodulin Stimulated Phosphodiesterase from <i>Brachypodium distachyon</i>
by: Mateusz Kwiatkowski, et al.
Published: (2021-09-01)

Targeting PDE10A GAF Domain with Small Molecules: A Way for Allosteric Modulation with Anti-Inflammatory Effects
by: Ana M. García, et al.
Published: (2017-09-01)

Phosphodiesterase 4B: Master Regulator of Brain Signaling
by: Amy J. Tibbo, et al.
Published: (2020-05-01)

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats
by: Yajuan Wang, et al.
Published: (2011-09-01)

Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway
by: Siwen Liu, et al.
Published: (2020-11-01)

NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants
by: Issaka Yougbare, et al.
Published: (2020-08-01)

Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis
by: Qian Zhou, et al.
Published: (2023-03-01)

Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey
by: Kunal Shah B, et al.
Published: (2012-03-01)